Clinical aspects of Hyaline Fibromatosis Syndrome and identification of a novel mutation

被引：15

作者：

Haerter, Bettina ^{[1
]}

Benedicenti, Francesco ^{[2
,3
]}

Karall, Daniela ^{[4
]}

Lausch, Ekkehard ^{[5
]}

Schweigmann, Gisela ^{[6
]}

Stanzial, Franco ^{[2
,3
]}

Superti-Furga, Andrea ^{[7
]}

Scholl-Buergi, Sabine ^{[4
]}

机构：

[1] Innsbruck Med Univ, Div Pediat Surg, Dept Visceral Transplant & Thorac Surg, Ctr Operat Med, Anichstr 35, A-6020 Innsbruck, Austria

[2] Reg Hosp Bolzano, Clin Genet Serv, Bolzano, Italy

[3] Reg Hosp Bolzano, South Tyrol Coordinat Ctr Rare Dis, Dept Pediat, Bolzano, Italy

[4] Innsbruck Med Univ, Dept Pediat 1, Innsbruck, Austria

[5] Univ Freiburg, Pediat Genet Sect, Dept Pediat, Freiburg, Germany

[6] Innsbruck Med Univ, Dept Radiol, Innsbruck, Austria

[7] Univ Lausanne, Lausanne Univ Hosp, Div Genet Med, Lausanne, Switzerland

来源：

MOLECULAR GENETICS & GENOMIC MEDICINE | 2020年 / 8卷 / 06期

关键词：

ANTXR2; CMG2; Hyaline Fibromatosis Syndrome; infantile systemic hyalinosis; juvenile hyaline fibromatosis; INFANTILE SYSTEMIC HYALINOSIS;

D O I：

10.1002/mgg3.1203

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Background Hyaline fibromatosis syndrome is an autosomal recessive disease caused by mutations in ANTXR2 which leads to loss of function of the transmembrane protein anthrax toxin receptor 2. It is distinguished by characteristic skin lesions, gingival hyperplasia, joint and bone disease, and systemic involvement. Methods Based on the case of an 11-year-old female patient with typical features of hyaline fibromatosis syndrome and the underlying pathogenic compound heterozygote variants in ANTXR2 we discuss the genetic and clinical aspects of hyaline fibromatosis syndrome. Results The novel mutation in ANTXR2 (c.1223T>C, p.Leu408Pro variant) seems to allow for a protracted course of the disease. Conclusion Our findings add to the phenotypic, genetic, and biochemical spectrum of hyaline fibromatosis syndrome.

引用

页数：6

共 16 条

[1] CMG2/ANTXR2 regulates extracellular collagen VI which accumulates in hyaline fibromatosis syndrome [J].

Burgi, Jerome ;

Kunz, Beatrice ;

Abrami, Laurence ;

Deuquet, Julie ;

Piersigilli, Alessandra ;

Scholl-Buergi, Sabine ;

Lausch, Ekkehart ;

Unger, Sheila ;

Superti-Furga, Andrea ;

Bonaldo, Paolo ;

van der Goot, F. Gisou .

NATURE COMMUNICATIONS, 2017, 8

[2] The dark sides of capillary morphogenesis gene 2 [J].

Deuquet, Julie ;

Lausch, Ekkehart ;

Superti-Furga, Andrea ;

van der Goot, F. Gisou .

EMBO JOURNAL, 2012, 31 (01) :3-13

[3] Hyaline Fibromatosis Syndrome inducing mutations in the ectodomain of anthrax toxin receptor 2 can be rescued by proteasome inhibitors [J].

Deuquet, Julie ;

Lausch, Ekkehart ;

Guex, Nicolas ;

Abrami, Laurence ;

Salvi, Suzanne ;

Lakkaraju, Asvin ;

Ramirez, Maria Celeste M. ;

Martignetti, John A. ;

Rokicki, Dariusz ;

Bonafe, Luisa ;

Superti-Furga, Andrea ;

van der Goot, Francoise G. .

EMBO MOLECULAR MEDICINE, 2011, 3 (04) :208-221

[4] Systemic Hyalinosis Mutations in the CMG2 Ectodomain Leading to Loss of Function Through Retention in the Endoplasmic Reticulum [J].

Deuquet, Julie ;

Abrami, Laurence ;

Difeo, Analisa ;

Ramirez, Maria Celeste M. ;

Martignetti, John A. ;

van der Goot, F. Gisou .

HUMAN MUTATION, 2009, 30 (04) :583-589

[5] Mutations in capillary morphogenesis gene-2 result in the allelic disorders juvenile hyaline fibromatosis and infantile systemic hyalinosis [J].

Dowling, O ;

Difeo, A ;

Ramirez, MC ;

Tukel, T ;

Narla, G ;

Bonafe, L ;

Kayserili, H ;

Yuksel-Apak, M ;

Paller, AS ;

Norton, K ;

Teebi, AS ;

Grum-Tokars, V ;

Martin, GS ;

Davis, GE ;

Glucksman, MJ ;

Martignetti, JA .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (04) :957-966

[6] Gingival Hyperplasia Associated With Juvenile Hyaline Fibromatosis: A Case Report and Review of the Literature [J].

El-Maaytah, Mohammed ;

Jerjes, Waseem ;

Shah, Priya ;

Upile, Tahwinder ;

Murphy, C. ;

Ayliffe, Peter .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2010, 68 (10) :2604-2608

[7] Mutations in the gene encoding capillary morphogenesis protein 2 cause juvenile hyaline fibromatosis and infantile systemic hyalinosis [J].

Hanks, S ;

Adams, S ;

Douglas, J ;

Arbour, L ;

Atherton, DJ ;

Balci, S ;

Bode, H ;

Campbell, ME ;

Feingold, M ;

Keser, G ;

Kleijer, W ;

Mancini, G ;

McGrath, JA ;

Muntoni, F ;

Nanda, A ;

Teare, MD ;

Warman, M ;

Pope, FM ;

Superti-Furga, A ;

Futreal, PA ;

Rahman, N .

AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (04) :791-800

[8] Infantile systemic hyalinosis: Case report and review of the literature [J].

Lindvall, Lisa E. ;

Kormeili, Tanya ;

Chen, Elaine ;

Ramirez, Maria Celeste M. ;

Grum-Tokars, Valerie ;

Glucksman, Marc J. ;

Martignetti, John A. ;

Zaragoza, Michael V. ;

Dyson, Senait W. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) :303-307

[9] Juvenile hyaline fibromatosis and infantile systemic hyalinosis: A unifying term and a proposed grading system [J].

Nofal, Ahmad ;

Sanad, Mohammad ;

Assaf, Magda ;

Nofal, Eman ;

Nassar, Amani ;

Almokadem, Sahar ;

Attwa, Enayat ;

Elmosalamy, Khaled .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 61 (04) :695-700

[10] Systemic hyalinosis:: A distinctive early childhood-onset disorder characterized by mutations in the anthrax toxin receptor 2 gene (ANTRX2) [J].

Shieh, Joseph T. C. ;

Swidler, Petra ;

Martignetti, John A. ;

Ramirez, Maria Celeste M. ;

Balboni, Imelda ;

Kaplan, Julie ;

Kennedy, Jeanette ;

Abdul-Rahman, Omar ;

Enns, Gregory M. ;

Sandborg, Christy ;

Slavotinek, Anne ;

Hoyme, H. Eugene .

PEDIATRICS, 2006, 118 (05) :E1485-E1492

← 1 2 →